SCHEMBL5887864

SCHEMBL5887864

FC(F)(F)c1cn[c]c(-c2ccc(Cl)c(Cl)c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF20B Q96Q89 1/20 0.44
AHR P35869 3/20 0.39
KMT2A Q03164 1/20 0.38
RAD51 Q06609 1/20 0.36
CYP1B1 Q16678 1/20 0.35
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 1/20 0.35
POLB P06746 1/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
MAPK1 P28482 1/20 0.35
GYS1 P13807 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34
KLRK1 P26718 1/20 0.34
MICA Q29983 1/20 0.34
RAET1L Q5VY80 1/20 0.34
NOTUM Q6P988 1/20 0.33
EIF4E P06730 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4502544 0.79 GPR55 (0.39) SMN1; SMN2KDM4EPOLBNPC1RAB9A
SCHEMBL5121903 0.70 AHR (0.45) AHRCYP1B1ALDH1A1KDM4ENPC1
SCHEMBL394514 0.70 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2KDM4EPOLBNPC1
SCHEMBL4810970 0.68 AHR (0.46) AHRCYP1B1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL29402881 0.65 TSHR (0.61) KIF20BAHRKMT2ARAD51ALDH1A1
SCHEMBL980201 0.65 TSHR (0.61) KIF20BAHRKMT2ARAD51ALDH1A1
SCHEMBL403256 0.64 ALDH1A1 (0.32) ALDH1A1SMN1; SMN2KDM4EPOLBL3MBTL1
SCHEMBL2120862 0.64 ALDH1A1 (0.32) ALDH1A1SMN1; SMN2KDM4EPOLB
Ammonia Solution, Strong SCHEMBL28020319 0.63 TSHR (0.58) KIF20BAHRKMT2ARAD51ALDH1A1
SCHEMBL1034476 0.63 AGBL2 (0.36) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7037931-B2 Corticotropin releasing factor moderator; analgesics; drug abruse, drug dependency; schizophrenia JANSSEN PHARMACEUTICA N.V. (BE) 2006-05-02 US claimed